Elekta AB (publ) (OTCMKTS:EKTAY) Reaches New 52-Week Low – What’s Next?

Elekta AB (publ) (OTCMKTS:EKTAYGet Free Report) hit a new 52-week low on Monday . The stock traded as low as $5.17 and last traded at $5.20, with a volume of 24026 shares changing hands. The stock had previously closed at $5.34.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein upgraded Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

View Our Latest Stock Analysis on Elekta AB (publ)

Elekta AB (publ) Stock Down 2.6 %

The stock has a market cap of $1.99 billion, a price-to-earnings ratio of 20.80 and a beta of 1.25. The stock has a 50 day simple moving average of $5.75 and a 200 day simple moving average of $5.93. The company has a quick ratio of 0.81, a current ratio of 1.05 and a debt-to-equity ratio of 0.60.

Elekta AB (publ) (OTCMKTS:EKTAYGet Free Report) last posted its quarterly earnings results on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. The business had revenue of $416.86 million during the quarter, compared to analyst estimates of $435.89 million. As a group, analysts expect that Elekta AB will post 0.36 earnings per share for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The firm also recently announced a dividend, which was paid on Thursday, March 27th. Investors of record on Friday, March 7th were issued a $0.1072 dividend. The ex-dividend date of this dividend was Friday, March 7th. Elekta AB (publ)’s dividend payout ratio is presently 44.00%.

About Elekta AB (publ)

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

See Also

Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.